Van Andel Institute
The Van Andel Institute and two West Michigan hospitals within the national Trinity Health system and members of Mercy Health – Saint Mary’s Health Care and Mercy Health Partners – have signed agreements paving the way for the expansion of a biorepository, using the VAI Program for Biospecimen Science.
Van Andel Institute hosted a scientific symposium Sept. 19-20 that gathered some of the world’s most noted experts in Parkinson’s disease and reinforced the region’s growing reputation in the field of Parkinson’s research.
The Van Andel Institute Wednesday announced that researchers at Lund University in Sweden have published a study detailing how Parkinson’s disease spreads through the brain. Experiments in rat models uncover a process previously used to explain mad cow disease, in which misfolded proteins travel from sick to healthy cells.
A discovery by Van Andel Institute researchers has identified a potential drug target for NK/T-cell lymphoma, a type of cancer responsible for claiming the life of a close friend and fellow researcher.
Researchers from South Korea, Sweden, and the United States have collaborated on a project to restore neuron function to parts of the brain damaged by Huntington’s disease by successfully transplanting HD-induced pluripotent stem cells into animal models.
Representatives from eight research institutions will convene at the Van Andel Institute Friday for a day of networking and sharing best practices.
A recent discovery by Van Andel Research Institute scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma — the most common and most aggressive malignant brain tumor in humans.
Two recent studies by Van Andel Research Institute scientists are providing a foundation for a more complete understanding of distinct kidney cancer subtypes, which could pave the way for better treatments.
Grand Valley State University and the Van Andel Institute will host more than 250 high school students during MichBio Student Career Day on Tuesday, Nov. 1.
Researchers from Michigan State University’s College of Human Medicine, Van Andel Research Institute and the Translational Genomics Research Institute are investigating a drug that has the potential to not only alleviate Parkinson’s symptoms but also halt the disease’s progression.